Journal ArticleDOI
L’IRM cardiaque dans les hémochromatoses primaires ou secondaires : 15 minutes pour comprendre
Charles Roux,M. Bravertti,S. Boussouar-Jacqueta,W. Turki,D. Toledano,N. Dabhi,N. Dabhi,Philippe Cluzel,Philippe Cluzel,Alban Redheuil,Alban Redheuil +10 more
TLDR
The IRM cardiaque as mentioned in this paper is le seul examen non invasif permettant de quantifier precisement la surcharge en fer myocardique and de l’evaluer tout au long du traitement.About:
This article is published in Journal d'imagerie diagnostique et interventionnelle.The article was published on 2018-10-01. It has received 0 citations till now.read more
References
More filters
Journal ArticleDOI
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
Lisa J. Anderson,S Holden,Bernard A. Davis,Emma Prescott,CC Charrier,N Bunce,David N. Firmin,Beatrix Wonke,John B. Porter,John Walker,Dudley J. Pennell +10 more
TL;DR: Myocardial iron deposition can be reproducibly quantified using myocardial T2* and this is the most significant variable for predicting the need for ventricular dysfunction treatment, and early intensification of iron chelation therapy should reduce mortality from this reversible cardiomyopathy.
Journal ArticleDOI
Cardiovascular Function and Treatment in β-Thalassemia Major: A Consensus Statement From the American Heart Association
Dudley J. Pennell,James E. Udelson,Andrew E. Arai,Biykem Bozkurt,Alan R. Cohen,Renzo Galanello,Timothy M. Hoffman,Michael S. Kiernan,Stamatios Lerakis,Antonio Piga,John B. Porter,John Walker,John C. Wood +12 more
TL;DR: In this article, the authors report an expert consensus on the diagnosis and treatment of cardiac dysfunction in β-thalassemia major (TM), which does not cover other hemoglobias.
Cardiovascular Function and Treatment in β-Thalassemia Major A Consensus Statement From the American Heart Association Endorsed by the Thalassaemia International Federation, European Society of Cardiology Working Group on Cardiovascular Magnetic Resonance, and Society for Cardiovascular Magnetic Resonance
Dudley J. Pennell,James E. Udelson,Andrew E. Arai,Biykem Bozkurt,Alan R. Cohen,Renzo Galanello,Timothy M. Hoffman,Michael S. Kiernan,Stamatios Lerakis,Antonio Piga,John Porter,John Walker,John C. Wood +12 more
TL;DR: An expert consensus is reported on the diagnosis and treatment of cardiac dysfunction in β-thalassemia major (TM), which does not cover other hemoglobinopathies, including thalassemia intermedia and sickle cell anemia, in which a different spectrum of cardiovascular complications is typical.
Journal ArticleDOI
Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major
Mark Westwood,Beatrix Wonke,Alicia M. Maceira,Emma Prescott,J Malcolm Walker,John B. Porter,Dudley J. Pennell +6 more
TL;DR: To compare left ventricular (LV) diastolic function with myocardial iron levels in beta thalassemia major patients, using cardiovascular magnetic resonance (CMR) patients is used.
Journal ArticleDOI
F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization.
Matthias Schmidt,E. Voth,Christian Schneider,Peter Theissen,Rainer Wagner,Frank M. Baer,Harald Schicha +6 more
TL;DR: Quantitative assessment of dobutamine induced systolic wall thickening by MRI and F-18-FDG-uptake by PET are highly accurate techniques for the identification of viable myocardium and prediction of functional recovery after successful revascularization.